These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 22123576)

  • 1. [Association of acute lymphoblastic leukaemia and visceral leishmaniasis].
    Nafil H; Tazi I; Mahmal L
    Ann Biol Clin (Paris); 2011; 69(6):729-31. PubMed ID: 22123576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and epidemiological features of visceral leishmaniasis and HIV co-infection in fifteen patients from Brazil.
    Daher EF; Fonseca PP; Gerhard ES; Leitão TM; Silva Júnior GB
    J Parasitol; 2009 Jun; 95(3):652-5. PubMed ID: 19642802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient.
    Boumis E; Chinello P; Della Rocca C; Paglia MG; Proietti MF; Petrosillo N
    Int J STD AIDS; 2006 May; 17(5):351-3. PubMed ID: 16643688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kala-azar in Afghanistan.
    Singh M; Arya LS; Aram GN; Fazal MI; Qureshi MA; Goel RG
    J Trop Med Hyg; 1982 Oct; 85(5):201-4. PubMed ID: 7176002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visceral childhood leishmaniasis in southern Turkey: experience of twenty years.
    Dursun O; Erişir S; Yeşilipek A
    Turk J Pediatr; 2009; 51(1):1-5. PubMed ID: 19378883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphotericin B lipid complex versus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV: a randomized pilot study.
    Laguna F; Videla S; Jiménez-Mejías ME; Sirera G; Torre-Cisneros J; Ribera E; Prados D; Clotet B; Sust M; López-Vélez R; Alvar J;
    J Antimicrob Chemother; 2003 Sep; 52(3):464-8. PubMed ID: 12888588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Kala-azar. Apropos of a case report in a Belgian woman].
    Coutellier P; Delgrange B
    Acta Clin Belg; 1989; 44(5):362-3. PubMed ID: 2609847
    [No Abstract]   [Full Text] [Related]  

  • 8. Visceral leishmaniasis in HIV-1-infected individuals: a common opportunistic infection in Spain?
    Medrano FJ; Hernández-Quero J; Jiménez E; Pineda JA; Rivero A; Sánchez-Quijano A; Velez ID; Viciana P; Castillo R; Reyes MJ
    AIDS; 1992 Dec; 6(12):1499-503. PubMed ID: 1362880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meglumine antimoniate-induced pancreatitis.
    Torrús D; Massa B; Boix V; Portilla J; Pérez-Mateo M
    Am J Gastroenterol; 1996 Apr; 91(4):820-1. PubMed ID: 8677970
    [No Abstract]   [Full Text] [Related]  

  • 10. Mediterranean visceral leishmaniasis in pregnancy.
    Gradoni L; Gaeta GB; Pellizzer G; Maisto A; Scalone A
    Scand J Infect Dis; 1994; 26(5):627-9. PubMed ID: 7855563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visceral leishmaniasis during pregnancy treated with meglumine antimoniate.
    Utili R; Rambaldi A; Tripodi MF; Andreana A
    Infection; 1995; 23(3):182-3. PubMed ID: 7499009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Visceral leishmaniasis: a possible diagnosis in Belgium].
    Desmyttere S; Hachimi-Idrissi S; Otten J
    Tijdschr Kindergeneeskd; 1993 Oct; 61(5):182-5. PubMed ID: 8266313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visceral leishmaniasis and disseminated intravascular coagulation in a dog.
    Font A; Gines C; Closa JM; Mascort J
    J Am Vet Med Assoc; 1994 Apr; 204(7):1043-4. PubMed ID: 8045804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Visceral leishmaniasis as an opportunistic infection. Our experience].
    Masseo A; Raimo C; Foti G; Pellicanò S; Foti N
    Minerva Med; 1989 Mar; 80(3):303-4. PubMed ID: 2717051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Visceral leishmaniasis: a study of 15 cases].
    Laguna F; Gazapo E; Martínez P; Enriquez A; Puente S; García Aguado C; González Lahoz JM
    An Med Interna; 1992 Apr; 9(4):161-4. PubMed ID: 1581449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of bone marrow amastigotes in a child with kala-azar and acute lymphoblastic leukaemia.
    Grech V; Vella C; Lenicker H
    Ann Trop Paediatr; 2000 Sep; 20(3):237-8. PubMed ID: 11064779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AA-amyloidosis caused by visceral leishmaniasis in a human immunodeficiency virus-infected patient.
    de Vallière S; Mary C; Joneberg JE; Rotman S; Bullani R; Greub G; Gillmore JD; Buffet PA; Tarr PE
    Am J Trop Med Hyg; 2009 Aug; 81(2):209-12. PubMed ID: 19635871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute pancreatitis associated with the administration of meglumine antimonate for the treatment of visceral leishmaniasis.
    de Lalla F; Pellizzer G; Gradoni L; Vespignani M; Franzetti M; Stecca C
    Clin Infect Dis; 1993 May; 16(5):730-1. PubMed ID: 8507769
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytogenetic observations after meglumine antimoniate therapy for visceral leishmaniasis.
    Hantson P; Léonard ED; Crutzen-Fayt MC; Léonard A; Vandercam B; Delaere B; Mahieu P
    Pharmacotherapy; 1996; 16(5):869-71. PubMed ID: 8888081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of kala azar.
    Ozsoylu S
    Lancet; 1996 Jun; 347(9016):1701. PubMed ID: 8642997
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.